Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NOVN save search
Ligand’s Partner Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Published: 2023-01-06 (Crawled : 15:20) - biospace.com/
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.0%
H: 1.96%
C: -26.96%
LGND | $70.87 1.4% 1.38% 150K
|
Health Technology
|
| O: 0.59%
H: 1.57%
C: 0.17%
sb206 molluscum treatment fda drug application
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Published: 2023-01-06 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.0%
H: 1.96%
C: -26.96%
sb206 molluscum treatment fda drug application
EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan
Published: 2022-12-21 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.86%
H: 10.43%
C: 7.83%
rhofade japan license agreement
EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
Published: 2022-12-02 (Crawled : 13:00) - novan.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 10.53%
H: 12.7%
C: -7.94%
HTBK | $8.35 0.6% 0.6% 310K
|
Finance
|
| O: -0.84%
H: 0.78%
C: 0.0%
agreement
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
Published: 2022-12-01 (Crawled : 14:00) - novan.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 4.21%
H: 19.68%
C: 15.15%
conference medical aesthetic
Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 2.94%
H: 0.95%
C: -17.09%
financial update results
Novan to Report Third Quarter 2022 Financial Results on November 14, 2022
Published: 2022-11-07 (Crawled : 14:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.88%
H: 10.43%
C: 4.35%
report financial results
EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference®
Published: 2022-10-21 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.97%
H: 6.7%
C: 3.85%
unique therapeutics
EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference®
Published: 2022-10-21 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.97%
H: 6.7%
C: 3.85%
conference therapeutics psoriasis
Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®
Published: 2022-10-14 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.42%
H: 0.0%
C: -4.13%
conference presentation
EPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA® (calcipotriene and betamethasone dipropionate) Cream, 0.005%/0.064% Subgroup Data Analysis at Skin of Color Update 2022 Conference
Published: 2022-09-15 (Crawled : 12:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -1.24%
H: 2.64%
C: -0.84%
wynzora conference skin therapeutics update
Novan Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 11:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -1.03%
H: 7.32%
C: 1.39%
update results
Novan to Report Second Quarter 2022 Financial Results on August 11, 2022
Published: 2022-08-04 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 1.1%
H: 1.09%
C: -0.36%
report results
Novan Satisfies $16.5 Million Outstanding Promissory Note
Published: 2022-07-19 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 11.52%
H: 0.0%
C: -4.8%
Novan Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology
Published: 2022-07-13 (Crawled : 16:00) - prnewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -2.0%
H: 22.45%
C: 4.08%
sb206 molluscum positive results publication study phase 3
Novan Announces Closing of Approximately $15.0 Million Registered Direct Offering Priced At-the-Market
Published: 2022-06-13 (Crawled : 21:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 1.69%
H: 2.49%
C: -3.32%
offering
Novan Announces Approximately $15.0 Million Registered Direct Offering Priced At-the-Market
Published: 2022-06-09 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -10.21%
H: 6.27%
C: 5.1%
offering
Novan to Present Berdazimer Gel, 10.3% (SB206) Clinical Data at Annual Meeting of the Society for Investigative Dermatology
Published: 2022-05-19 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.0%
H: 19.31%
C: 12.74%
sb206
Novan Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-05-16 (Crawled : 11:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -3.63%
H: 7.53%
C: 6.28%
results
Novan to Report First Quarter 2022 Financial Results on May 16, 2022
Published: 2022-05-06 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -3.87%
H: 0.37%
C: -3.3%
report results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.